Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3187107
Max Phase: Preclinical
Molecular Formula: C14H16N4O
Molecular Weight: 256.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3187107
Max Phase: Preclinical
Molecular Formula: C14H16N4O
Molecular Weight: 256.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nc(NC(=O)c2ccccc2)cc(N(C)C)n1
Standard InChI: InChI=1S/C14H16N4O/c1-10-15-12(9-13(16-10)18(2)3)17-14(19)11-7-5-4-6-8-11/h4-9H,1-3H3,(H,15,16,17,19)
Standard InChI Key: NHXUTYHYFMCOIM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 256.31 | Molecular Weight (Monoisotopic): 256.1324 | AlogP: 2.10 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.12 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.98 | CX Basic pKa: 4.73 | CX LogP: 3.07 | CX LogD: 3.07 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.91 | Np Likeness Score: -1.76 |
1. PubChem BioAssay data set, |
Source(1):